Navigation Links
Quorum IRB Board Chair to Speak at South Korean Research Summit

Seattle, WA (PRWEB) September 17, 2013

Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, will speak at the 2013 Global Clinical Research Summit to be held Oct. 1 and 2 in Daegu, South Korea. This year’s gathering will focus on the “Innovative, Integrative and Personalized Care Approach” in worldwide human subject research.

Dr. Rosenfeld’s discussion on Oct. 1 is entitled “CIM Challenge to Global Unique Model as Pioneer” and will cover how to perform rigorous research combining western therapeutic practice and traditional Korean medicine. This will mark the first time a member of the Quorum Review Board presents in Asia since the renowned IRB expanded its services to international markets outside of the U.S. and Canada.

As previously announced, Dr. Rosenfeld was recently appointed to the Secretary’s Advisory Committee on Human Research Protections (SACHRP), an exclusive panel that advises the U.S. Secretary of Health and Human Services in the area of human research subjects. His appearance at the summit is expected to combine the detailed approach he employs as Quorum Review’s Board Chair with that of his broader scope as a SACHRP member who is improving the research oversight process.

Rosenfeld says, “It's an honor to be representing Quorum Review IRB in South Korea at this prestigious event, and I am looking forward to contributing to the international perspective on human clinical research.”

For the latest on Quorum Review News and Events, visit

About Quorum Review IRB

Quorum Review is an independent review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the United States and internationally, a specialized Phase I team, and unique processes for post-approval and registry studies.


Arri Burgess
Director, Client Relations & Marketing
Quorum Review IRB
(206) 436-3244

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. Quorum Review IRB and ConsentSolutions Form Strategic Alliance
3. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
4. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
5. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
6. GenturaDx Announces Formation of Scientific Advisory Board
7. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
8. DiaTech Life Sciences Announces Medical Advisory Board
9. BioStorage Technologies Appoints New Member to Board of Directors
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015  Symic, a clinical-stage ... the extracellular matrix (ECM), today announced that it has ... advance the company,s pipeline, including its lead candidates SB-030 ... and includes the participation by all existing major investors, ... brings the total capital raised by Symic to over ...
(Date:12/1/2015)... 1, 2015 Dr. Harry Lander , President of Regen, ... Chief Science Officer and recruits five distinguished ... , President of Regen, expands his role to include ... recruits five distinguished scientists to join advisory team ... his role to include serving as Chief ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Matthew “Tex” ... new post, VerMilyea will oversee all IVF lab procedures as well as ... fertility preservation. , “We traveled 7,305 miles to Auckland, New Zealand to bring home ...
(Date:11/30/2015)... ... 2015 , ... Global Stem Cells Group Chile ... Central America and abroad for the first Iberoamerican Convention on Aesthetic Medicine, Cosmetology ... Testart will present and discuss new trends in anti-aging stem cell treatments, regenerative ...
Breaking Biology Technology:
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
Breaking Biology News(10 mins):